These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 30895762)

  • 1. Antihypertensive effect of sacubitril/valsartan: a meta-analysis.
    De Vecchis R; Ariano C; Soreca S
    Minerva Cardioangiol; 2019 Jun; 67(3):214-222. PubMed ID: 30895762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of Sacubitril/Valsartan (LCZ696) Compared With Olmesartan in Elderly Asian Patients (≥65 Years) With Systolic Hypertension.
    Supasyndh O; Wang J; Hafeez K; Zhang Y; Zhang J; Rakugi H
    Am J Hypertens; 2017 Nov; 30(12):1163-1169. PubMed ID: 28992296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Hypertensive Effect of Sacubitril/Valsartan: A Meta-Analysis of Randomized Controlled Trials.
    De Vecchis R; Soreca S; Ariano C
    Cardiol Res; 2019 Feb; 10(1):24-33. PubMed ID: 30834056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Network meta-analysis of sacubitril/valsartan for the treatment of essential hypertension.
    Zhang Y; Zhao X; Huang H; Li M
    Clin Res Cardiol; 2023 Jul; 112(7):855-867. PubMed ID: 36326841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term (52-week) safety and efficacy of Sacubitril/valsartan in Asian patients with hypertension.
    Supasyndh O; Sun N; Kario K; Hafeez K; Zhang J
    Hypertens Res; 2017 May; 40(5):472-476. PubMed ID: 27853163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different Doses of Sacubitril/Valsartan Compared with Olmesartan in Patients with Essential Hypertension: A Systematic Review and Meta-Analysis.
    Almarjan AI; Almarjan SA; Masoud AT
    High Blood Press Cardiovasc Prev; 2023 May; 30(3):207-218. PubMed ID: 37017901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of Sacubitril/Valsartan in Chronic Type B Aortic Dissection Combined With Mild Hypertension.
    Wang X; Song F; Jiang L; Huang Z; Luo S; Li X; He X
    Am J Hypertens; 2024 Jul; 37(8):612-620. PubMed ID: 38564196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Safety Comparative of Sacubitril/Valsartan vs. Olmesartan in the Treatment of hypertension: A Meta-analysis of RCTs.
    Han Y; Zhou Y; Na J; Li F; Sun Y
    Am J Hypertens; 2023 Nov; 36(12):643-650. PubMed ID: 37596996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of sacubitril/valsartan in the treatment of middle-aged and elderly patients with hypertension: a systematic review and meta-analysis of randomized controlled trials.
    Wu HX; Liu KK; Li BN; Liu S; Jin JC
    Ann Palliat Med; 2022 May; 11(5):1811-1825. PubMed ID: 35672897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of sacubitril/valsartan compared with olmesartan in Asian patients with essential hypertension: A randomized, double-blind, 8-week study.
    Huo Y; Li W; Webb R; Zhao L; Wang Q; Guo W
    J Clin Hypertens (Greenwich); 2019 Jan; 21(1):67-76. PubMed ID: 30536595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect and safety of LCZ696 in the treatment of hypertension: A meta-analysis of 9 RCT studies.
    Li Q; Li L; Wang F; Zhang W; Guo Y; Wang F; Liu Y; Jia J; Lin S
    Medicine (Baltimore); 2019 Jul; 98(28):e16093. PubMed ID: 31305392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of sacubitril/valsartan versus olmesartan in Japanese patients with essential hypertension: a randomized, double-blind, multicenter study.
    Rakugi H; Kario K; Yamaguchi M; Sasajima T; Gotou H; Zhang J
    Hypertens Res; 2022 May; 45(5):824-833. PubMed ID: 35058583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of sacubitril/valsartan with olmesartan for hypertension: A meta-analysis of randomized controlled trials.
    Sun Y; Yang H
    Medicine (Baltimore); 2024 Apr; 103(14):e37501. PubMed ID: 38579097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihypertensive Effects of Sacubitril/Valsartan Versus Olmesartan: An Updated Systemic Review and Meta-Analysis of Randomized Controlled Trials.
    Raja R; Kumari S; Umer Khan M; Ayaz A; Jaffar D; Mohamad Z; Muzammil MA; Sohail N; Ahmed Qureshi S; Saeed H; Fahad Amin M; Jawad A; Varrassi G; Kumar S; Khatri M; Maryam A
    Cureus; 2023 Nov; 15(11):e48692. PubMed ID: 38090459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and Safety of LCZ696 for Short-term Management of Essential Hypertension Compared With ARBs: A Meta-analysis of Randomized Controlled Trials.
    Yang S; Zhang H; Yang P; Wang C; Wu Q
    J Cardiovasc Pharmacol; 2021 May; 77(5):650-659. PubMed ID: 33951700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of sacubitril/valsartan compared to olmesartan on cardiovascular remodelling in subjects with essential hypertension: the results of a randomized, double-blind, active-controlled study.
    Schmieder RE; Wagner F; Mayr M; Delles C; Ott C; Keicher C; Hrabak-Paar M; Heye T; Aichner S; Khder Y; Yates D; Albrecht D; Langenickel T; Freyhardt P; Janka R; Bremerich J
    Eur Heart J; 2017 Nov; 38(44):3308-3317. PubMed ID: 29029087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of sacubitril/valsartan (LCZ696) add-on to amlodipine in Asian patients with systolic hypertension uncontrolled with amlodipine monotherapy.
    Wang JG; Yukisada K; Sibulo A; Hafeez K; Jia Y; Zhang J
    J Hypertens; 2017 Apr; 35(4):877-885. PubMed ID: 28030431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Sacubitril/Valsartan in Hypertension.
    Malik AH; Aronow WS
    Am J Ther; 2022 May-Jun 01; 29(3):e322-e333. PubMed ID: 30664018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of sacubitril/valsartan in patients with heart failure and chronic kidney disease: A meta-analysis.
    Kang H; Zhang J; Zhang X; Qin G; Wang K; Deng Z; Fang Y; Chen G
    Eur J Pharmacol; 2020 Oct; 884():173444. PubMed ID: 32739172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of LCZ696 (Sacubitril/Valsartan) on Blood Pressure in Patients with Hypertension: A Meta-Analysis of Randomized Controlled Trials.
    Geng Q; Yan R; Wang Z; Hou F
    Cardiology; 2020; 145(9):589-598. PubMed ID: 32726791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.